The latest edition of the AfricaFocus Bulletin states: "Despite continued US refusal to allow the use of cost-effective generic drugs in its international AIDS programs, there is momentum on other fronts in the international campaign to give priority to health and development needs over narrow interpretations of patent rights. The European Commission on October 29 proposed a new regulation to allow generic drug manufacturers to produce patented medicines for exports. Earlier in October, the World Intellectual Property Organization (WIPO) adopted a proposal by developing countries to fully integrate development priorities into its consideration of intellectual property issues." This edition of AfricaFocus Bulletin contains further details on this issue.